What is the recommended metoprolol dosing and titration strategy for treating hypertension in a 51-year-old Caucasian male?

Metoprolol is NOT a First-Line Agent for Hypertension in This Patient

For a 51-year-old Caucasian male with uncomplicated hypertension, metoprolol should not be used as initial therapy—start with an ACE inhibitor or ARB at low dose, then add a dihydropyridine calcium channel blocker or thiazide-like diuretic if needed. 1

Why Beta-Blockers Are Not First-Line

The 2020 International Society of Hypertension guidelines explicitly position beta-blockers (including metoprolol) as fifth-line therapy for non-Black patients with hypertension 1. The treatment algorithm for non-Black patients is clear:

1. First-line: Low-dose ACE inhibitor or ARB
2. Second-line: Add dihydropyridine calcium channel blocker
3. Third-line: Increase to full dose
4. Fourth-line: Add thiazide/thiazide-like diuretic
5. Fifth-line: Add spironolactone or, if not tolerated, amiloride, doxazosin, eplerenone, clonidine, or beta-blocker

The 2024 ESC guidelines similarly recommend beta-blockers only when there are compelling indications such as angina, post-myocardial infarction, heart failure with reduced ejection fraction, or need for heart rate control 2. The 2025 AHA/ACC guidelines echo this approach 3.

When Metoprolol IS Appropriate

Beta-blockers become appropriate first-line therapy when specific comorbidities exist:

• Coronary artery disease with angina
• Post-myocardial infarction (target dose 200 mg daily metoprolol succinate) 4
• Heart failure with reduced ejection fraction
• Atrial fibrillation requiring rate control
• Hypertensive emergencies with acute aortic dissection (combined with vasodilators) 5

If Metoprolol Must Be Used: Dosing Strategy

Should compelling indications exist, the evidence supports:

Starting Dose

• Metoprolol tartrate: 25-50 mg twice daily 6, 7
• Metoprolol succinate (extended-release): 50-100 mg once daily 7, 8

The extended-release formulation is preferred for once-daily dosing to improve adherence 1, 7.

Titration Schedule

• Week 0-4: Start at 100 mg daily (succinate) or 50 mg twice daily (tartrate)
• Week 4: If diastolic BP remains ≥95 mmHg, increase to 200 mg daily (succinate) or 100 mg twice daily (tartrate) 7
• Maximum dose: 200-400 mg daily, though doses above 200 mg show a relatively flat dose-response curve 9

Monitoring

• Check BP and heart rate at 2-4 weeks
• Achieve target BP <130/80 mmHg within 3 months 1, 2
• Monitor for bradycardia (heart rate <60 bpm may indicate excessive dosing)

Critical Pitfalls to Avoid

1. Don't use metoprolol as monotherapy for uncomplicated hypertension in this patient—it's not evidence-based for mortality reduction compared to ACE inhibitors/ARBs 1, 10

2. Avoid in patients with:

   • Active asthma or reactive airways disease 4
   • Second- or third-degree heart block 4
   • Decompensated heart failure 4
   • Severe peripheral vascular disease

3. Don't abruptly discontinue—taper over 1-2 weeks to avoid rebound hypertension and tachycardia

4. Elderly patients (>65 years): Start at lower doses (25 mg twice daily or 50 mg daily) with cautious titration due to decreased hepatic metabolism 6, 11

The Bottom Line

Unless this 51-year-old has coronary disease, post-MI status, heart failure, or arrhythmia requiring rate control, initiate therapy with an ACE inhibitor or ARB as per guideline-directed therapy. Metoprolol can be added later if BP remains uncontrolled after optimizing first-line agents, or used immediately if compelling cardiac indications exist. The goal is BP <130/80 mmHg within 3 months using the most evidence-based approach for reducing cardiovascular morbidity and mortality 1, 3, 2.